UNION CITY, Calif., Oct. 18 /PRNewswire-FirstCall/ — Abaxis,
Inc. (Nasdaq:
ABAX), a medical products company manufacturing point-of-care
blood analysis systems, has scheduled a conference call to discuss
its financial results for the second quarter of fiscal year 2011,
ended September 30, 2010. The call will be at 4:15 p.m. ET on
Tuesday, October 26, 2010.
Participants can dial (877) 317-6789 or (412) 317-6789 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
company’s website at www.abaxis.com. A replay of the
call is available by visiting www.abaxis.com for the next 30
days or by calling (877) 344-7529 or (412) 317-0088, confirmation
code 445369, through October 29, 2010.
About AbaxisAbaxis develops, manufactures and markets
portable blood analysis systems for use in any veterinary or human
patient-care setting to provide clinicians with rapid blood
constituent measurements. The system consists of a compact,
5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the
chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The
system can be operated with minimal training and performs multiple
routine tests on whole blood, serum or plasma samples. The
system provides test results in less than 12 minutes with the
precision and accuracy equivalent to a clinical laboratory
analyzer. Contact:
Clint Severson
Lytham Partners, LLCChief Executive Officer
Joe Dorame, Joe Diaz & Robert BlumAbaxis, Inc.
602-889-9700510-675-6500
‘/>”/>
SOURCE
